In an impoverished nation battered by war, hunger, poverty and drought, an invisible virus is considered fake or an afterthought.
The developments, which came nearly a week after 1 million doses of the vaccine arrived in South Africa, were a huge setback for the country.
Centre extends ban on UK flights till 7 Jan, advises caution on New Year's eve; cases of new COVID-19 strain rise to 20
An expert panel met to consider the Emergency Use Authorisation (EUA) requests of Pfizer, Serum Institute of India (SII) and Bharat Biotech for their COVID-19 vaccine candidates. As per reports, the SEC said it will reconvene on 1 January.
Centre says strict COVID-19 guidelines to be followed till 31 Jan; 2-day vaccine dry run begins in four states
The home ministry said there has been a continuous decline in the active and new COVID-19 cases in the country but there is a need to maintain caution, in view of the surge in the number of cases globally and a new virus strain being detected in the UK
SII rejects Covishield volunteer's allegations; PM to interact with 3 teams making COVID vaccine today
A 40-year-old man who took part in the 'Covishield' vaccine trial in Chennai has alleged serious side effects, including a virtual neurological breakdown and impairment of cognitive functions and has sought compensation of Rs 5 crore
The prime minister is visiting the top vaccine hubs to 'get a first-hand perspective of the roadmap in India's endeavour to vaccinate its citizens', said the PMO